The demand for human albumin in Italy

Blood Transfusion

Volumn 11, Issue SUPPL. 4, 2013, Pages

  Vaglio, Stefania ^a,b   Calizzani, Gabriele ^a   Lanzoni, Monica ^a,c   Candura, Fabio ^a   Profili, Samantha ^a   Catalano, Liviana ^a   Cannata, Livia ^a   Liumbruno, Giancarlo M ^d   Grazzini, Giuliano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Albumin infusion; Albumin preparation; Analysis of demand; Human albumin; Plasma derived medicinal product

Indexed keywords

ALBIOMIN; ALBUNORM; ALBUREX; FLEXBUMIN; HUMAN ALBUMIN; HUMAN SERUM ALBUMIN; OCTALBIN; UMANALBUMIN; UMANSERUM; UNCLASSIFIED DRUG;

DRUG MARKETING; HEALTH CARE FACILITY; ITALY; REVIEW;

HUMANS; ISOTONIC SOLUTIONS; ITALY; PLASMA SUBSTITUTES; SERUM ALBUMIN;

EID: 84885666835     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2013.006s     Document Type: Review

References (12)

1. European Medicines Agency. Committee for Medicinal Products for Human use (CHMP). Guideline on the Core SPC for human albumin solution (EMA/CHMP/BPWP/494462/2011 rev.3). 2012. Available at: http://www.ema.europa.eu/ docs/en-GB/document-library/Scientific-guideline/2012/06/WC500129278.pdf. Accessed on 13/08/2013.
2. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.
3. Provincial Blood Coordinating Office BC Ministry of Health. Guidelines for Albumin Use for Adults in British Columbia. October 2007. Available at: http://www.pbco.ca/images/UM/Albumin/guidelines-for-albumin-use-in-bc- 28oct200729.pdf. Accessed on 05/08/2013.
4. National Plasma Product Expert Advisory Group. Clinical Guidelines for Human Albumin Use. Available at: http://www.nsd.scot.nhs.uk/documents/ guidelines/albumingdl.pdf. Accessed on 05/08/2013.
5. Bruce AR. AASLD practice guideline. Management of adult patients with ascites due to cirrhosis: update 2012. Available at: http://www.aasld.org/ practiceguidelines/Documents/ascitesupdate2013.pdf. Accessed on 05/08/2013.
6. National Plasma Product Expert Advisory Group. Guidelines for the Usage of Human Albumin Solution. Available at: http://www.nsd.scot.nhs.uk/Documents/ ClinGuidelinesHumanAlbu minJune2012.pdf. Accessed on 05/08/2013.
7. Liumbruno GM, Bennardello F, Lattanzio A, et al. Italian Society of Transfusion Medicine and Immunohaematology (SIMTI). Recommendations for the use of albumin and immunoglobulins. Blood Transfus 2009; 7: 216-34.
8. Burnouf T. Modern plasma fractionation. Transfus Med Rev 2007; 21: 101-17. (Pubitemid 46482990)
9. Nota 15. Agenzia Italiana del Farmaco. Available at: http://www. agenziafarmaco.gov.it/it/content/nota-15. Accessed on 13/08/2013.
10. st, 2006. Decreto Legislativo 24 aprile 2006, n. 219 "Attuazione della direttiva 2001/83/CE (e successive direttive di modifica) relativa ad un codice comunitario concernente i medicinali per uso umano, nonché della direttiva 2003/94/CE". Available at: http://www.agenziafarmaco.gov.it/sites/default/files/DL-2006-219-0. pdf. Accessed on 30/08/2013.
11. Lanzoni M, Biffoli C, Candura F, et al. Plasma-derived medicinal products in Italy: information sources and flows. Blood Transfus 2013; 11 (Suppl 4): s13-7.
12. Robert P. The Marketing Research Bureau (MRB). The Worldwide Plasma Fractions Market 2008. April 2010 Ed. Orange, CT: The Marketing Research Bureau, Inc.; 2010.